mSphere of Influence: The bacterial growth law—revisiting the old to discover the new
mSphere · 28.07.2026 · 11 (7)
DOI: 10.1128/msphere.00046-26 ↗Kurz gefasst
Fachartikel in der Zeitschrift mSphere, erschienen am 28.07.2026. Verfasst von Katsuya Fuchino. Beteiligte Einrichtung: Centre for Bacterial Cell Biology, Biosciences Institute, Newcastle University, Newcastle upon Tyne, United Kingdom. Hauptthemen laut MEDLINE: Salmonella typhimurium, Bacteria. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Katsuya Fuchino works in the field of bacterial cell biology and applied microbiology. In this mSphere of Influence article, he reflects on how the studies “Dependency on medium and temperature of cell size and chemical composition during balanced growth of Salmonella typhimurium ” by Schaechter et al. and “A metabolic sensor governing cell size in bacteria” by Weart et al. inspired the field of bacterial cell size homeostasis and his current research. Additionally, he highlights the value of reading classic, original papers that influenced the field, as a means to reflect on paradigm shifts and generate new ideas.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Bacterial Cell Biology, Biosciences Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
ORCID-Profile: Katsuya Fuchino
Zitieren
APA
Fuchino, K. (2026). mSphere of Influence: The bacterial growth law—revisiting the old to discover the new. mSphere, 11(7). https://doi.org/10.1128/msphere.00046-26
Vancouver
Fuchino K. mSphere of Influence: The bacterial growth law—revisiting the old to discover the new. mSphere. 2026;11(7). doi:10.1128/msphere.00046-26
BibTeX
@article{Fuchino2026,
author = {Fuchino, Katsuya},
title = {mSphere of Influence: The bacterial growth law—revisiting the old to discover the new},
journal = {mSphere},
year = {2026},
volume = {11},
number = {7},
doi = {10.1128/msphere.00046-26}
}
EUVIMED